ModerateClass IITerminated

FDA Devices recall · Reported September 21, 2022

Acidified Concentrate Distribution and Storage-The Isopure ACDS (Acidified Concentrate Distribution and Storage) with remote fill is intended to be used in Hemodialysis facilities for the storage and distribution of acid concentrate to be used in the treatment of Hemodialysis patients Model: ACDS MD704262

Q: Which agency issued this recall?

This recall was issued by the FDA Devices on September 21, 2022. Severity: Moderate. Recall number: Z-1739-2022.

Q: Where was the recalled product distributed?

Distribution: US Nationwide distribution..

Q: Should I stop using a recalled medication or medical device?

Do not stop using a recalled medication or device without consulting your healthcare provider first, as abruptly discontinuing treatment could pose its own health risks. Your doctor can advise on alternatives or whether the recall applies to your specific product lot. Check the recall number and lot information against your product packaging.

Acidified Concentrate Distribution System potential electrical safety hazard may result in electric shock, arching

Recall #: Z-1739-2022
Affected scope: 595 units
Initiated: July 26, 2022

Compiled from official public sources by the publisher. · Updated September 2026

Verify with FDA Devices →

View my saved recalls

Isopure Corp recalled Acidified Concentrate Distribution and Storage-The Isopure ACDS (Acidified Concentrate Di… - a moderate-severity action.

Acidified Concentrate Distribution and Storage-The Isopure ACDS (Acidified Concentrate Di… was recalled by Isopure Corp in September 21, 2022. Reason: Acidified Concentrate Distribution System potential electrical safety hazard may result in electric shock, ar…. Check the official notice for the remedy. Verify recall #Z-1739-2022 with the FDA Devices before acting.

The recall

Isopure Corp issued this moderate-severity FDA Devices recall-Acidified Concentrate Distribution System potential electrical safety hazard may result in electric shock, ar….

Moderate
severity level: 595 units
affected scope: Class II
classification: September 21, 2022
reported

Sourced from official FDA Devices enforcement records. Verify recall #Z-1739-2022 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.

Recall Insight

This recall's affected scope, documented in the Recall Profile below, stays within a single-region or limited-distribution footprint. Distribution scope (see Distribution below) directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.

Within the same product category the archive holds 6 closely related recalls, 6 from FDA Devices - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.

Where this agency-classified recall sits among FDA Class I/II/III notices

Of 88,244 recalls with an agency hazard classification, 19,068 are high severity, 64,652 moderate, and 4,524 low. A further 16,179 CPSC/NHTSA recalls have no agency class and are excluded from this split. This recall is classified moderate severity.

Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.

Product description

Acidified Concentrate Distribution and Storage-The Isopure ACDS (Acidified Concentrate Distribution and Storage) with remote fill is intended to be used in Hemodialysis facilities for the storage and distribution of acid concentrate to be used in the treatment of Hemodialysis patients Model: ACDS MD704262

Reason for recall

Acidified Concentrate Distribution System potential electrical safety hazard may result in electric shock, arching

Recall Profile

Structured summary of the FDA Devices recall record
Attribute	Value
Agency	U.S. Food and Drug Administration
Severity class	Moderate (Class II)
Status	Terminated
Recall number	Z-1739-2022
Date reported	September 21, 2022
Date initiated	July 26, 2022
Recalling firm	Isopure Corp
Firm location	Louisville, KY
Affected scope	595 units
Distribution	US Nationwide distribution.

Profile values are sourced directly from the official FDA Devices enforcement record. Source: U.S. Food and Drug Administration.

Scale of Impact

595 units units affected - limited or regional distribution scale.

Regional (<10K units) ✓ This recall

Multi-state (10K – 100K units) -

Large-scale (100K – 1M units) -

Massive (≥1M units) -

Bracket cutoffs follow federal recall-disclosure conventions; bar widths scale linearly within each bracket. Source: PlainRecalls analysis of U.S. Food and Drug Administration filings.

What to do with this recall

Match your product against the recall record, then act on the agency remedy.

Check the recall number (Z-1739-2022) and product description against the item you own. Search the archive
Confirm the current status with FDA Devices before acting, recall details can be updated.
Follow the documented remedy (refund, replacement, repair, or disposal) rather than general advice. What to do next

This page summarizes the official FDA Devices record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.

Frequently Asked Questions

What product was recalled? ▼

Why was this product recalled? ▼

Acidified Concentrate Distribution System potential electrical safety hazard may result in electric shock, arching

Which agency issued this recall? ▼

This recall was issued by the FDA Devices on September 21, 2022. Severity: Moderate. Recall number: Z-1739-2022.

Where was the recalled product distributed? ▼

Distribution: US Nationwide distribution..

Should I stop using a recalled medication or medical device? ▼

Do not stop using a recalled medication or device without consulting your healthcare provider first, as abruptly discontinuing treatment could pose its own health risks. Your doctor can advise on alternatives or whether the recall applies to your specific product lot. Check the recall number and lot information against your product packaging.

Nationwide recalls with similar severity or category timing

Drug and device notices outside this firm and state, matched by severity timing and product category.

Similar severity · nearest report date

Same archive severity grade (Moderate), closest by report date among other firms and states.

Magnesium Citrate SALINE LAXATIVE, Oral S… 2022-09-21 Magnesium Citrate SALINE LAXATIVE, Oral S… 2022-09-21 Magnesium Citrate SALINE LAXATIVE, Oral S… 2022-09-21 Bupivacaine HCl 0.375% w/v and Lidocaine … 2022-09-21

Similar Medical Devices · nearest report date

Same product category, closest by report date among other firms and states (deduped against the severity set).

L-Carnitine 500 mg/mL Injectable, 10 ML v… 2022-09-21 MIC/B12 25/50/50/1 MG/ML Injectable, 10 M… 2022-09-21 MIC/B12/L-Carn (HD) 35/35/35/1/35 MG/ML I… 2022-09-21 Sermorelin Acetate 1 MG/ML Injectable, 9 … 2022-09-21

Compare this recall with GORE VIABIL Short Wire Biliary Endoprosthesis, Model No. VS… → · All Medical Devices recalls

This recall: FDA Devices, reported September 21, 2022. Severity classes follow each agency's own taxonomy; related-recall context is computed across the full archive.

Methodology · Corrections · Archive as of August 2026